An exploratory factor analysis of the children's depression rating scale-revised. 2006

Ying Guo, and Mary E Nilsson, and John Heiligenstein, and Michael G Wilson, and Graham Emslie
Department of Biostatistics, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.

An exploratory factor analysis was performed in a clinical sample of 314 children and adolescents to investigate the factor structure of the Children's Depression Rating Scale-Revised (CDRS-R; Poznanski et al. 1984). A maximum likelihood method followed by a Promax rotation yielded five factors: observed depressive mood, anhedonia, morbid thoughts, somatic symptoms and reported depressive mood. The age group and gender differences on the factors scores are evaluated. After controlling for gender, the adolescents had more severe depression in terms of observed depressive mood, anhedonia, and somatic symptoms. After controlling for age groups, girls had higher scores for reported depressive mood.

UI MeSH Term Description Entries
D008297 Male Males
D010552 Personality Assessment The determination and evaluation of personality attributes by interviews, observations, tests, or scales. Articles concerning personality measurement are considered to be within scope of this term. Assessment, Personality,Assessments, Personality,Personality Assessments
D011594 Psychometrics Assessment of psychological variables by the application of mathematical procedures. Psychometric
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003865 Depressive Disorder, Major Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5) Depression, Involutional,Major Depressive Disorder,Melancholia, Involutional,Paraphrenia, Involutional,Psychosis, Involutional,Depressive Disorders, Major,Involutional Depression,Involutional Melancholia,Involutional Paraphrenia,Involutional Paraphrenias,Involutional Psychoses,Involutional Psychosis,Major Depressive Disorders,Paraphrenias, Involutional,Psychoses, Involutional
D005163 Factor Analysis, Statistical A set of statistical methods for analyzing the correlations among several variables in order to estimate the number of fundamental dimensions that underlie the observed data and to describe and measure those dimensions. It is used frequently in the development of scoring systems for rating scales and questionnaires. Analysis, Factor,Analysis, Statistical Factor,Factor Analysis,Statistical Factor Analysis,Analyses, Factor,Analyses, Statistical Factor,Factor Analyses,Factor Analyses, Statistical,Statistical Factor Analyses
D005260 Female Females
D005473 Fluoxetine The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants. Fluoxetin,Fluoxetine Hydrochloride,Lilly-110140,N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine,Prozac,Sarafem,Lilly 110140,Lilly110140
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Ying Guo, and Mary E Nilsson, and John Heiligenstein, and Michael G Wilson, and Graham Emslie
December 2010, Journal of child and adolescent psychopharmacology,
Ying Guo, and Mary E Nilsson, and John Heiligenstein, and Michael G Wilson, and Graham Emslie
May 2018, Journal of child and adolescent psychopharmacology,
Ying Guo, and Mary E Nilsson, and John Heiligenstein, and Michael G Wilson, and Graham Emslie
December 2001, Journal of clinical child psychology,
Ying Guo, and Mary E Nilsson, and John Heiligenstein, and Michael G Wilson, and Graham Emslie
January 2005, International journal of adolescent medicine and health,
Ying Guo, and Mary E Nilsson, and John Heiligenstein, and Michael G Wilson, and Graham Emslie
July 2012, Mental illness,
Ying Guo, and Mary E Nilsson, and John Heiligenstein, and Michael G Wilson, and Graham Emslie
August 2014, Journal of child and adolescent psychopharmacology,
Ying Guo, and Mary E Nilsson, and John Heiligenstein, and Michael G Wilson, and Graham Emslie
May 2022, Journal of child and adolescent psychopharmacology,
Ying Guo, and Mary E Nilsson, and John Heiligenstein, and Michael G Wilson, and Graham Emslie
April 2018, Journal of affective disorders,
Ying Guo, and Mary E Nilsson, and John Heiligenstein, and Michael G Wilson, and Graham Emslie
April 1999, The Journal of social psychology,
Copied contents to your clipboard!